table of content
1 Study Coverage
1.1 RNA Drugs Product Introduction
1.2 Market by Type
1.2.1 Global RNA Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 Market by Application
1.3.1 Global RNA Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global RNA Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global RNA Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global RNA Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global RNA Drugs Sales by Region
2.4.1 Global RNA Drugs Sales by Region (2017-2022)
2.4.2 Global Sales RNA Drugs by Region (2023-2028)
2.5 Global RNA Drugs Revenue by Region
2.5.1 Global RNA Drugs Revenue by Region (2017-2022)
2.5.2 Global RNA Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global RNA Drugs Sales by Manufacturers
3.1.1 Global Top RNA Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global RNA Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of RNA Drugs in 2021
3.2 Global RNA Drugs Revenue by Manufacturers
3.2.1 Global RNA Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global RNA Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by RNA Drugs Revenue in 2021
3.3 Global RNA Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global RNA Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global RNA Drugs Sales by Type
4.1.1 Global RNA Drugs Historical Sales by Type (2017-2022)
4.1.2 Global RNA Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global RNA Drugs Sales Market Share by Type (2017-2028)
4.2 Global RNA Drugs Revenue by Type
4.2.1 Global RNA Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global RNA Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global RNA Drugs Revenue Market Share by Type (2017-2028)
4.3 Global RNA Drugs Price by Type
4.3.1 Global RNA Drugs Price by Type (2017-2022)
4.3.2 Global RNA Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global RNA Drugs Sales by Application
5.1.1 Global RNA Drugs Historical Sales by Application (2017-2022)
5.1.2 Global RNA Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global RNA Drugs Sales Market Share by Application (2017-2028)
5.2 Global RNA Drugs Revenue by Application
5.2.1 Global RNA Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global RNA Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global RNA Drugs Revenue Market Share by Application (2017-2028)
5.3 Global RNA Drugs Price by Application
5.3.1 Global RNA Drugs Price by Application (2017-2022)
5.3.2 Global RNA Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America RNA Drugs Market Size by Type
6.1.1 North America RNA Drugs Sales by Type (2017-2028)
6.1.2 North America RNA Drugs Revenue by Type (2017-2028)
6.2 North America RNA Drugs Market Size by Application
6.2.1 North America RNA Drugs Sales by Application (2017-2028)
6.2.2 North America RNA Drugs Revenue by Application (2017-2028)
6.3 North America RNA Drugs Market Size by Country
6.3.1 North America RNA Drugs Sales by Country (2017-2028)
6.3.2 North America RNA Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe RNA Drugs Market Size by Type
7.1.1 Europe RNA Drugs Sales by Type (2017-2028)
7.1.2 Europe RNA Drugs Revenue by Type (2017-2028)
7.2 Europe RNA Drugs Market Size by Application
7.2.1 Europe RNA Drugs Sales by Application (2017-2028)
7.2.2 Europe RNA Drugs Revenue by Application (2017-2028)
7.3 Europe RNA Drugs Market Size by Country
7.3.1 Europe RNA Drugs Sales by Country (2017-2028)
7.3.2 Europe RNA Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific RNA Drugs Market Size by Type
8.1.1 Asia Pacific RNA Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific RNA Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific RNA Drugs Market Size by Application
8.2.1 Asia Pacific RNA Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific RNA Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific RNA Drugs Market Size by Region
8.3.1 Asia Pacific RNA Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific RNA Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America RNA Drugs Market Size by Type
9.1.1 Latin America RNA Drugs Sales by Type (2017-2028)
9.1.2 Latin America RNA Drugs Revenue by Type (2017-2028)
9.2 Latin America RNA Drugs Market Size by Application
9.2.1 Latin America RNA Drugs Sales by Application (2017-2028)
9.2.2 Latin America RNA Drugs Revenue by Application (2017-2028)
9.3 Latin America RNA Drugs Market Size by Country
9.3.1 Latin America RNA Drugs Sales by Country (2017-2028)
9.3.2 Latin America RNA Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa RNA Drugs Market Size by Type
10.1.1 Middle East and Africa RNA Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa RNA Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa RNA Drugs Market Size by Application
10.2.1 Middle East and Africa RNA Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa RNA Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa RNA Drugs Market Size by Country
10.3.1 Middle East and Africa RNA Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa RNA Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Overview
11.2.3 Roche RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Roche RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Overview
11.3.3 Sanofi-Aventis RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi-Aventis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Aventis Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Overview
11.4.3 Abbott Laboratories RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Abbott Laboratories RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Laboratories Recent Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Corporation Information
11.5.2 Arrowhead Pharmaceuticals Overview
11.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Arrowhead Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Arrowhead Pharmaceuticals Recent Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Corporation Information
11.6.2 Benitec Biopharma Overview
11.6.3 Benitec Biopharma RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Benitec Biopharma RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Benitec Biopharma Recent Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Corporation Information
11.7.2 Calimmune Inc Overview
11.7.3 Calimmune Inc RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Calimmune Inc RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Calimmune Inc Recent Developments
11.8 Dicerna
11.8.1 Dicerna Corporation Information
11.8.2 Dicerna Overview
11.8.3 Dicerna RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dicerna RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dicerna Recent Developments
11.9 Gradalis
11.9.1 Gradalis Corporation Information
11.9.2 Gradalis Overview
11.9.3 Gradalis RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Gradalis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Gradalis Recent Developments
11.10 Quark
11.10.1 Quark Corporation Information
11.10.2 Quark Overview
11.10.3 Quark RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Quark RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Quark Recent Developments
11.11 RXi
11.11.1 RXi Corporation Information
11.11.2 RXi Overview
11.11.3 RXi RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 RXi RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 RXi Recent Developments
11.12 Senesco
11.12.1 Senesco Corporation Information
11.12.2 Senesco Overview
11.12.3 Senesco RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Senesco RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Senesco Recent Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Corporation Information
11.13.2 Silence Therapeutics Overview
11.13.3 Silence Therapeutics RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Silence Therapeutics RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Silence Therapeutics Recent Developments
11.14 Silenseed
11.14.1 Silenseed Corporation Information
11.14.2 Silenseed Overview
11.14.3 Silenseed RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Silenseed RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Silenseed Recent Developments
11.15 Tekmira
11.15.1 Tekmira Corporation Information
11.15.2 Tekmira Overview
11.15.3 Tekmira RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Tekmira RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tekmira Recent Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Corporation Information
11.16.2 Alnylam Pharmaceuticals Overview
11.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Alnylam Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alnylam Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 RNA Drugs Industry Chain Analysis
12.2 RNA Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 RNA Drugs Production Mode & Process
12.4 RNA Drugs Sales and Marketing
12.4.1 RNA Drugs Sales Channels
12.4.2 RNA Drugs Distributors
12.5 RNA Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 RNA Drugs Industry Trends
13.2 RNA Drugs Market Drivers
13.3 RNA Drugs Market Challenges
13.4 RNA Drugs Market Restraints
14 Key Findings in The Global RNA Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
